StockData
Treace Medical Concepts, Inc. logo

Treace Medical Concepts, Inc. (TMCI) stock

TMCINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/3016% below fair value
$5.27−0.07 (-1.31%)

Close on Nov 13, 2026Market cap $342.73MP/E –Yield –

Treace Medical Concepts EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Treace Medical Concepts's EV/EBITDA was 680.3× on Jul 30, 2021.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2021Jul 30, 2021680.3×–

More Treace Medical Concepts figures

See a number that looks wrong?